Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Competitive Fitness of Essential Gene Knockdowns Reveals a Broad-Spectrum Antibacterial Inhibitor of the Cell Division Protein FtsZ.

Hogan AM, Scoffone VC, Makarov V, Gislason AS, Tesfu H, Stietz MS, Brassinga AKC, Domaratzki M, Li X, Azzalin A, Biggiogera M, Riabova O, Monakhova N, Chiarelli LR, Riccardi G, Buroni S, Cardona ST.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e01231-18. doi: 10.1128/AAC.01231-18. Print 2018 Dec.

2.

Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study.

Buroni S, Scoffone VC, Fumagalli M, Makarov V, Cagnone M, Trespidi G, De Rossi E, Forneris F, Riccardi G, Chiarelli LR.

Front Pharmacol. 2018 Jul 31;9:836. doi: 10.3389/fphar.2018.00836. eCollection 2018.

3.

Antimicrobial activity of six essential oils against Burkholderia cepacia complex: insights into mechanism(s) of action.

Perrin E, Maggini V, Maida I, Gallo E, Lombardo K, Madarena MP, Buroni S, Scoffone VC, Firenzuoli F, Mengoni A, Fani R.

Future Microbiol. 2018 Jan;13:59-67. doi: 10.2217/fmb-2017-0121. Epub 2017 Dec 4.

PMID:
29199856
4.

Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance.

Perrin E, Fondi M, Bosi E, Mengoni A, Buroni S, Scoffone VC, Valvano M, Fani R.

BMC Genomics. 2017 Oct 30;18(1):834. doi: 10.1186/s12864-017-4222-4.

5.

Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.

Scoffone VC, Chiarelli LR, Trespidi G, Mentasti M, Riccardi G, Buroni S.

Front Microbiol. 2017 Aug 22;8:1592. doi: 10.3389/fmicb.2017.01592. eCollection 2017. Review.

6.

Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections.

Israyilova A, Buroni S, Forneris F, Scoffone VC, Shixaliyev NQ, Riccardi G, Chiarelli LR.

PLoS One. 2016 Nov 29;11(11):e0167350. doi: 10.1371/journal.pone.0167350. eCollection 2016.

7.

Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo.

Scoffone VC, Chiarelli LR, Makarov V, Brackman G, Israyilova A, Azzalin A, Forneris F, Riabova O, Savina S, Coenye T, Riccardi G, Buroni S.

Sci Rep. 2016 Sep 1;6:32487. doi: 10.1038/srep32487.

8.

The Crystal Structure of Burkholderia cenocepacia DfsA Provides Insights into Substrate Recognition and Quorum Sensing Fatty Acid Biosynthesis.

Spadaro F, Scoffone VC, Chiarelli LR, Fumagalli M, Buroni S, Riccardi G, Forneris F.

Biochemistry. 2016 Jun 14;55(23):3241-50. doi: 10.1021/acs.biochem.6b00178. Epub 2016 Jun 2.

PMID:
27198181
9.

Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia.

Scoffone VC, Ryabova O, Makarov V, Iadarola P, Fumagalli M, Fondi M, Fani R, De Rossi E, Riccardi G, Buroni S.

Front Microbiol. 2015 Aug 5;6:815. doi: 10.3389/fmicb.2015.00815. eCollection 2015.

10.

Differential roles of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells.

Buroni S, Matthijs N, Spadaro F, Van Acker H, Scoffone VC, Pasca MR, Riccardi G, Coenye T.

Antimicrob Agents Chemother. 2014 Dec;58(12):7424-9. doi: 10.1128/AAC.03800-14. Epub 2014 Sep 29.

11.

Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis.

Albesa-Jové D, Chiarelli LR, Makarov V, Pasca MR, Urresti S, Mori G, Salina E, Vocat A, Comino N, Mohorko E, Ryabova S, Pfieiffer B, Lopes Ribeiro AL, Rodrigo-Unzueta A, Tersa M, Zanoni G, Buroni S, Altmann KH, Hartkoorn RC, Glockshuber R, Cole ST, Riccardi G, Guerin ME.

ACS Chem Biol. 2014 Jul 18;9(7):1567-75. doi: 10.1021/cb500149m. Epub 2014 Jun 13.

12.

Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia.

Scoffone VC, Spadaro F, Udine C, Makarov V, Fondi M, Fani R, De Rossi E, Riccardi G, Buroni S.

Antimicrob Agents Chemother. 2014;58(4):2415-7. doi: 10.1128/AAC.02438-13. Epub 2014 Jan 6.

13.

A census of RND superfamily proteins in the Burkholderia genus.

Perrin E, Fondi M, Papaleo MC, Maida I, Emiliani G, Buroni S, Pasca MR, Riccardi G, Fani R.

Future Microbiol. 2013 Jul;8(7):923-37. doi: 10.2217/fmb.13.50.

PMID:
23841637
14.

Phenotypic and genotypic characterisation of Burkholderia cenocepacia J2315 mutants affected in homoserine lactone and diffusible signal factor-based quorum sensing systems suggests interplay between both types of systems.

Udine C, Brackman G, Bazzini S, Buroni S, Van Acker H, Pasca MR, Riccardi G, Coenye T.

PLoS One. 2013;8(1):e55112. doi: 10.1371/journal.pone.0055112. Epub 2013 Jan 28.

15.

Structural basis for benzothiazinone-mediated killing of Mycobacterium tuberculosis.

Neres J, Pojer F, Molteni E, Chiarelli LR, Dhar N, Boy-Röttger S, Buroni S, Fullam E, Degiacomi G, Lucarelli AP, Read RJ, Zanoni G, Edmondson DE, De Rossi E, Pasca MR, McKinney JD, Dyson PJ, Riccardi G, Mattevi A, Cole ST, Binda C.

Sci Transl Med. 2012 Sep 5;4(150):150ra121. doi: 10.1126/scitranslmed.3004395.

16.

Antituberculars which target decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1: state of art.

Buroni S, Pasca MR, de Jesus Lopes Ribeiro AL, Degiacomi G, Molteni E, Riccardi G.

Appl Microbiol Biotechnol. 2012 May;94(4):907-16. doi: 10.1007/s00253-012-4013-4. Epub 2012 Apr 18. Review. Retraction in: Appl Microbiol Biotechnol. 2012 Sep;95(5):1369.

PMID:
22526781
17.

Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1.

Trefzer C, Škovierová H, Buroni S, Bobovská A, Nenci S, Molteni E, Pojer F, Pasca MR, Makarov V, Cole ST, Riccardi G, Mikušová K, Johnsson K.

J Am Chem Soc. 2012 Jan 18;134(2):912-5. doi: 10.1021/ja211042r. Epub 2011 Dec 21.

PMID:
22188377
18.

Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis.

Ribeiro AL, Degiacomi G, Ewann F, Buroni S, Incandela ML, Chiarelli LR, Mori G, Kim J, Contreras-Dominguez M, Park YS, Han SJ, Brodin P, Valentini G, Rizzi M, Riccardi G, Pasca MR.

PLoS One. 2011;6(11):e26675. doi: 10.1371/journal.pone.0026675. Epub 2011 Nov 1.

19.

MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212.

La Rosa V, Poce G, Canseco JO, Buroni S, Pasca MR, Biava M, Raju RM, Porretta GC, Alfonso S, Battilocchio C, Javid B, Sorrentino F, Ioerger TR, Sacchettini JC, Manetti F, Botta M, De Logu A, Rubin EJ, De Rossi E.

Antimicrob Agents Chemother. 2012 Jan;56(1):324-31. doi: 10.1128/AAC.05270-11. Epub 2011 Oct 24.

20.

Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa multidrug resistance clinical isolates.

Pasca MR, Dalla Valle C, De Jesus Lopes Ribeiro AL, Buroni S, Papaleo MC, Bazzini S, Udine C, Incandela ML, Daffara S, Fani R, Riccardi G, Marone P.

Microb Drug Resist. 2012 Feb;18(1):23-32. doi: 10.1089/mdr.2011.0019. Epub 2011 Jul 28.

PMID:
21797666
21.

Deciphering the role of RND efflux transporters in Burkholderia cenocepacia.

Bazzini S, Udine C, Sass A, Pasca MR, Longo F, Emiliani G, Fondi M, Perrin E, Decorosi F, Viti C, Giovannetti L, Leoni L, Fani R, Riccardi G, Mahenthiralingam E, Buroni S.

PLoS One. 2011 Apr 19;6(4):e18902. doi: 10.1371/journal.pone.0018902.

22.

Molecular mechanisms of chlorhexidine tolerance in Burkholderia cenocepacia biofilms.

Coenye T, Van Acker H, Peeters E, Sass A, Buroni S, Riccardi G, Mahenthiralingam E.

Antimicrob Agents Chemother. 2011 May;55(5):1912-9. doi: 10.1128/AAC.01571-10. Epub 2011 Feb 28.

23.

Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis.

Lucarelli AP, Buroni S, Pasca MR, Rizzi M, Cavagnino A, Valentini G, Riccardi G, Chiarelli LR.

PLoS One. 2010 Nov 15;5(11):e15494. doi: 10.1371/journal.pone.0015494.

24.

Decaprenylphosphoryl-β-D-ribose 2'-epimerase from Mycobacterium tuberculosis is a magic drug target.

Manina G, Pasca MR, Buroni S, De Rossi E, Riccardi G.

Curr Med Chem. 2010;17(27):3099-108. Review.

PMID:
20629622
25.

Biological and structural characterization of the Mycobacterium smegmatis nitroreductase NfnB, and its role in benzothiazinone resistance.

Manina G, Bellinzoni M, Pasca MR, Neres J, Milano A, Ribeiro AL, Buroni S, Skovierová H, Dianišková P, Mikušová K, Marák J, Makarov V, Giganti D, Haouz A, Lucarelli AP, Degiacomi G, Piazza A, Chiarelli LR, De Rossi E, Salina E, Cole ST, Alzari PM, Riccardi G.

Mol Microbiol. 2010 Sep;77(5):1172-85. doi: 10.1111/j.1365-2958.2010.07277.x.

26.

Exploring the HME and HAE1 efflux systems in the genus Burkholderia.

Perrin E, Fondi M, Papaleo MC, Maida I, Buroni S, Pasca MR, Riccardi G, Fani R.

BMC Evol Biol. 2010 Jun 3;10:164. doi: 10.1186/1471-2148-10-164.

27.

Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator.

Bellinzoni M, Buroni S, Schaeffer F, Riccardi G, De Rossi E, Alzari PM.

J Bacteriol. 2009 Dec;191(24):7531-7. doi: 10.1128/JB.00631-09. Epub 2009 Oct 9.

28.

Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance.

Buroni S, Pasca MR, Flannagan RS, Bazzini S, Milano A, Bertani I, Venturi V, Valvano MA, Riccardi G.

BMC Microbiol. 2009 Sep 17;9:200. doi: 10.1186/1471-2180-9-200.

29.

Mycobacterium tuberculosis: drug resistance and future perspectives.

Riccardi G, Pasca MR, Buroni S.

Future Microbiol. 2009 Jun;4(5):597-614. doi: 10.2217/fmb.09.20. Review.

PMID:
19492969
30.

Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.

Makarov V, Manina G, Mikusova K, Möllmann U, Ryabova O, Saint-Joanis B, Dhar N, Pasca MR, Buroni S, Lucarelli AP, Milano A, De Rossi E, Belanova M, Bobovska A, Dianiskova P, Kordulakova J, Sala C, Fullam E, Schneider P, McKinney JD, Brodin P, Christophe T, Waddell S, Butcher P, Albrethsen J, Rosenkrands I, Brosch R, Nandi V, Bharath S, Gaonkar S, Shandil RK, Balasubramanian V, Balganesh T, Tyagi S, Grosset J, Riccardi G, Cole ST.

Science. 2009 May 8;324(5928):801-4. doi: 10.1126/science.1171583. Epub 2009 Mar 19.

31.

LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis.

Buroni S, Manina G, Guglierame P, Pasca MR, Riccardi G, De Rossi E.

Antimicrob Agents Chemother. 2006 Dec;50(12):4044-52. Epub 2006 Oct 16.

32.

Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome.

Guglierame P, Pasca MR, De Rossi E, Buroni S, Arrigo P, Manina G, Riccardi G.

BMC Microbiol. 2006 Jul 20;6:66.

33.

Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain.

Bellinzoni M, Buroni S, Pasca MR, Guglierame P, Arcesi F, De Rossi E, Riccardi G.

Res Microbiol. 2005 Mar;156(2):173-7.

PMID:
15748981

Supplemental Content

Loading ...
Support Center